Cocrystal Pharma (COCP) Stock Forecast: StockMap's 2-Week Call
COCP stock forecast: StockMap's model makes no two-week call on Cocrystal Pharma after the Nov 19 close: its evidence is split, 6 reasons for and 9 against. Right in 2 of 5 two-week windows on COCP since Aug 21; by chance, a call on the same dates was right 62% of the time.
Cocrystal Pharma last closed at $0.97, -1.02% on the session.
Against the IVW growth benchmark the position is +1.31% over the forecast window.
Cocrystal Pharma's market cap is $18.63M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -6 (too close to call).
Where COCP sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 6 bullish and 9 bearish.
Agreement across those insights is 60%.
30 daily calls for COCP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Cocrystal Pharma in the 3rd percentile on return on equity, where 100 is best.
Cocrystal Pharma is classified under Health Care / Pharmaceuticals.
StockMap tracks Cocrystal Pharma as the 125th largest of the 153 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.
Across that group the current two-week reads are 80 Moderate Underperform, 44 Neutral and 29 Strong Underperform.
On that composite Cocrystal Pharma ranks 21st of 153 in the group, against a group median of -0.36.